Thumb Arthritis Market Expands Rapidly: Rising Prevalence, Advanced Therapies, and 2024-2030 Growth Projections
Thumb arthritis, a debilitating condition affecting the carpometacarpal (CMC) joint of the thumb, is emerging as a critical focus in orthopedic and rheumatology markets. Characterized by pain, stiffness, and reduced grip strength, this condition primarily impacts adults over 50, with osteoarthritis being the most common cause. As global populations age and lifestyle factors (e.g., repetitive hand use, joint stress) increase risk, the thumb arthritis market is projected to grow at a CAGR of 5.8% from 2024 to 2030, according to industry analysts. This expansion is fueled not only by rising prevalence but also by advancements in targeted therapies and a shift toward patient-centric care models.
The aging demographic is a key driver. By 2030, the global population aged 65+ is expected to reach 1.5 billion, with thumb arthritis prevalence increasing by 2% per decade in this group.…
I read this discussion and think it is encouraging to see more attention being given to thumb arthritis because better treatments can improve daily life for many people. Early diagnosis and proper care can make a big difference over time. During a difficult semester, I was struggling with several subjects and even searched for college math exam takers for hire when I felt overwhelmed by deadlines. That experience taught me how important it is to stay organized from the beginning.